Mangoceuticals
Update in progressMGRX (NasdaqCM)
- Company RatingNeutralCompany RatingCombines sentiment and sustainability signals into an overall assessment of the company.Great · Good · Neutral · At Risk · Poor
- SectorHealthcare
- IndustryHealth Information Services
Mangoceuticals, Inc. develops, markets, and sells men’s wellness products through a U.S. telemedicine platform. It offers Mango erectile dysfunction products, Grow hair loss products, Mojo hormone balance products, and Slim weight loss products. It provides oral testosterone undecanoate for low testosterone under Prime, plus access to a licensed online pharmacy for prescribed meds. Online at MangoRX.com. Based in Dallas, Texas since 2021, a subsidiary of Cohen Enterprises, Inc.
Company score
- Sentiment
- -0.01
- SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
- Environment
- 0.00
- EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
- Social
- 0.13
- Governance
- -0.06
- GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
- Sustainability
- 0.02
- SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
- Impact Score
- 0.01
- Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive
Sort by
Order by
Timeframe
No news articles are available for this company yet.
Unable to load company news.
Loading more news
You're all caught up!